Back
Oral Manifestations of HIV
Importance of oral healthcare for HIV positive patients
Oral manifestations of HIV disease are common and include oral lesions and novel
presentations of previously known opportunistic diseases. Careful history taking
and detailed examination of the patient's oral cavity are important parts of the
physical examination and diagnosis requires appropriate investigative techniques.
Early recognition, diagnosis and treatment of HIV-associated oral lesions may reduce
morbidity.
The presence of these lesions may be an early diagnostic indicator of immunodeficiency
and HIV infection, may change the classification of the stage of HIV infection and
is a predictor of the progression of HIV disease. In addition a poorly functional
dentition can adversely affect the quality of life, further compromising the health
of the HIV afflicted patients, many of whom may already be malnourished
Fungal Lesions
Candidiasis
Oral candidiasis is most commonly associated with Candida albicans, although other
species, such as C. glabrata and C. tropicalis, are frequently part of the normal
oral flora. A number of factors predispose patients to develop candidiasis: infancy,
old age, antibiotic therapy, steroid and other immunosuppressive drugs, xerostomia,
anaemia, endocrine disorders, and primary and acquired immunodeficiency. Candidiasis
is a common finding in people with HIV infection. Reports describe oral candidiasis
during the acute stage of HIV infection, but it occurs most commonly with falling
CD4 + T-cell count in middle and late stages of HIV disease.
Clinical Features
The clinical appearances of oral candidiasis vary. The most common presentations
include pseudomembranous and erythematous candidiasis, which are equally predictive
of the development of AIDS and angular cheilitis. These lesions may be associated
with a variety of symptoms, including a burning mouth, problems eating spicy food
and changes in taste All three of these common forms may appear in one individual.
- Pseudomembranous Candidiasis (Thrush)
Characteristic creamy white, removable plaques on the oral mucosa are caused by
overgrowth of fungal hyphae mixed with desquamated epithelium and inflammatory cells.
The mucosa may appear red when the plaque is removed. This type of candidiasis may
involve any part of the mouth or pharynx.
- Erythematous Candidiasis
Erythematous candidiasis appears as flat, red patches of varying size. It commonly
occurs on the palate and the dorsal surface of the tongue. Erythematous candidiasis
is frequently subtle in appearance and clinicians may easily overlook lesions, which
may persist for several weeks if untreated.
- Angular Cheilitis
Angular cheilitis appears clinically as redness, ulceration and fissuring, either
unilaterally or bilaterally at the corners of the mouth. It can appear alone or
in conjunction with another form of candidiasis.
- Hyperplastic Candidiasis
This type of candidiasis is unusual in persons with HIV infection. The lesions appear
white and hyperplastic. The white areas are due to hyperkeratosis and unlike the
plaques of pseudomembranous candidiasis, cannot be removed by scraping. These lesions
may be confused with hairy leukoplakia. Diagnosis of hyperplastic candidiasis is
made from the histologic appearance of hyperkeratosis and the presence of hyphae.
Periodic acid-Schiff (PAS) stain is often used to demonstrate hyphae.
Differential Diagnosis
Erythematous candidiasis should be differentiated from other red lesions, such as
Kaposi's sarcoma or erythroplakia. Histologically, oral candidiasis contains Candida
hyphae in the superficial epithelium when viewed under a PAS stain. The inflammatory
responses often associated with Candida infection may be absent in immunocompromised
patients. The creamy white plaques of pseudomembranous candidiasis are removable;
the white lesions of hairy leukoplakia are nonremovable.
Diagnosis
Candida is a commensal organism in the oral cavity. Candidiasis is diagnosed by
its clinical appearance and by detection of organisms on smears. Smears taken from
clinical lesions are examined using potassium hydroxide (KOH), PAS or Gram's stain.
Smears are taken by gently drawing a wooden tongue depressor across the lesion.
The specimen is then transferred into a drop of KOH on a glass slide and protected
by a cover slip. The smear is examined under the microscope and Candida is detected
by finding hyphae and blastospores. Hyphae and spores are only seen in smears from
lesions and are rarely seen in the healthy individual in the carrier state. Cultures
are grown on specific media, such as Sabouraud's agar; they may be positive and
yet reveal very low colony counts. This probably represents a carrier state rather
than active infection. Culture is useful for establishing the Candida species but
may not be useful for diagnosis.
Treatment
Oral candidiasis may be treated either topically or systemically. Treatment should
be maintained for 7 days. Response to treatment is often good; oral lesions and
symptoms may disappear in a fairly short period (ranging from 2 to 5 days), but
relapses are common because of the underlying immunodeficiency. As with other causes
of oral candidiasis, recurrences are common if the underlying problem persists.
- Topical Treatment
Topical treatments are preferred because they limit systemic absorption, but the
effectiveness depends entirely on patient compliance. Topical medications require
that the patient hold medications in the mouth for 20 to 30 minutes. If the patient
uses formulations containing sweetening agents for long periods, consider as concurrent
treatment daily fluoride rinses (e.g., ACT or Fluorigard, available as over-the-counter
preparations) for 1 minute once a day and then expectorated.
Clotrimazole is an effective topical treatment (one oral troche [10-mg tablet])
when dissolved in the mouth five times daily. Used less frequently, one vaginal
troche can be dissolved in the mouth daily. Nystatin preparations include a suspension,
a vaginal tablet and an oral pastille. Regimens are nystatin vaginal tablets (one
tablet, 100,000 units, dissolved in the mouth three times a day) or nystatin oral
pastille (available as a 200,000-unit oral pastille, one or two pastilles dissolved
slowly in the mouth five times a day). Nystatin suspension has a high sugar content
and cannot be held in the mouth long enough to be effective. Topical creams and
ointments containing nystatin, ketoconazole or clotrimazole may be useful in treating
angular cheilitis. Another therapeutic choice is amphotericin B (0.1 mg/ml). Five
to 10 ml of oral solution is used as a rinse and then expectorated three to four
times daily.
- Systemic Treatment
Several agents are effective for systemic treatment. Ketoconazole (Nizoral) is a
200-mg tablet taken with food once daily. Patient compliance is usually good. Careful
monitoring of liver function is necessary for long-term use because of reported
side effects, including hepatotoxicity. Lack of efficacy of ketoconazole may occur
because of poor absorption in those with an abnormally high gastric pH.
Fluconazole (Diflucan) is a triazole antifungal agent effective in treating candidiasis
(100-mg tablet taken once daily for 2 weeks). Itraconazole (100-mg capsules) may
be used for the treatment of oral candidiasis (200 mg daily orally for 14 days).
Itraconazole oral suspension is now available (200 mg daily for 2 weeks). Salivary
levels of Itraconazole are maintained for several hours after administration.
Ketoconazole, fluconazole and itraconazole may interact with other medications including
rifampicin, phenytoin, cyclosporin A, terfenadine, digoxin, coumarin-like medications
and oral hypoglycemic medications.
Prognostic Significance
Both erythematous and pseudomembranous oral candidiasis are associated with increased
risk for the subsequent development of opportunistic infections classifying the
patient as having AIDS as defined by the Centers for Disease Control (CDC).Several
studies have shown a statistical correlation between frequency of oral candidiasis
in HIV infection and falling CD4 + T-cell counts.
Histoplasmosis
Histoplasmosis is an infection caused by the fungus. Histoplasma Capsulatum
Clinical Features
- 30-50% with disseminated histplasmosis may present with oral lesions.
- Oral lesions appear with ill defined margins and a granulomatous surface appearance.
- Cervical and submandibular lymphadenopathy is a feature.
- Gingival involvement often mimics severe periodontal disease.
- Diagnosis requires biopsy and histological examination of the specimen.
Treatment
- Patient should be referred to HIV specialist.
- Oral lesion scan be treated
with ketoconazole and amphotericin preparations.
Cryptococcus Neoformans
Clinical Features
- Nearly 10% of patients with cryptococcus develop lesions on the skin of the head
and neck region.
- Oral lesions are rare, when they do occur, oral lesions are ulcerative.
- Cryptococcus in AIDS patients is a fatal condition.
- A biopsy, histological examinations and tissue culture can confirm the diagnosis.
Treatment
- Ketoconazole and amphotericin B are the drugs of choice.
Viral lesions
Herpes Simplex
Herpes simplex causes both primary and secondary or recurrent disease in the oral
cavity. Primary herpetic gingivostomatitis commonly occurs in children and young
adults and may be followed by frequent recurrences. Following the primary episode,
the virus becomes latent in the trigeminal ganglion. Recurrent oral herpes occurs
at any age extraorally or intraorally.
Clinical Features
Recurrent herpes labialis occurs on the vermilion border of the lips. The patient
may report a history of itching or pain, followed by the appearance of small vesicles.
These rupture and form crusts. Recurrent intraoral herpes appears as clusters of
painful small vesicles that rupture and ulcerate and usually heal within 1 week
to 10 days. The lesions usually occur on the keratinized mucosa, such as the hard
palate and gingiva, although lesions may arise on the dorsal surface of the tongue.
Differential Diagnosis
Rising antibody titers from initial and convalescent sera confirm primary herpetic
gingivostomatitis. Examining smears of lesions (treated with Papanicolaou stain)
for multinucleated giant cells confirms recurrent herpes. It is possible to demonstrate
herpes simplex type 1 or type 2 by applying monoclonal antibodies to smears from
the lesions Swabs taken from fluid-filled vesicles may grow herpes simplex in culture
if vesicles are a few days or less old. Clinicians can distinguish between recurrent
intraoral herpes simplex lesions, which always occur on keratinized mucosa (such
as the hard palate and gingiva), and recurrent aphthous ulcers, which always appear
on nonkeratinized mucosa. Recurrent intraoral herpes may appear more frequently
in HIV-infected patients. The lesions may be painful and slow to heal.
Treatment
No treatment will permanently eradicate oral herpes simplex infections, but acyclovir
may shorten the healing time for individual episodes. The optimum oral dosage of
acyclovir is 1,000 to 1600 mg daily for 7 to 10 days. Topical acyclovir is not useful
for treating intraoral lesions and may not be effective for lesions on the lips.
Recurrent outbreaks of acyclovir-resistant herpes have been reported; the lesions
can be treated with foscarnet. Phosphonoformate may also prove effective.
Prognostic Significance
There is no known association between recurrent intraoral herpes and more rapid
progression of HIV disease. However, there is a clinical impression that recurrent
herpes simplex infections may be more common in patients with symptomatic HIV disease.
Herpes Zoster
The reactivation of varicella zoster virus (VZV) causes herpes zoster (shingles).
The disease occurs in the elderly and the immunosuppressed.
Clinical Features
Oral herpes zoster generally causes skin lesions. Following a prodromal of pain,
multiple vesicles appear on the facial skin, lips and oral mucosa. Skin and oral
lesions are frequently unilateral and follow the distribution of the maxillary and/or
mandibular branches of the trigeminal nerve. The skin lesions form crusts and the
oral lesions coalesce to form large ulcers. The ulcers frequently affect the gingiva,
so tooth pain may be an early complaint.
Differential Diagnosis
The appearance of the lesions and their distribution are pathognomonic.
Treatment
Acyclovir limits the duration of the lesions. For herpes zoster, the standard oral
dosage is 800 mg five daily for 7 to 10 days, which is considerably higher than
that recommended for treatment of herpes simplex.
Human Papillomavirus Lesions
Oral warts, papillomas, skin warts and genital warts are associated with the human
papillomavirus (HPV). Lesions caused by HPV are common on the skin and mucous membranes
of persons with HIV disease. Anal warts have frequently been reported among homosexual
men. Because the HPV types found in oral lesions in HIV-infected persons are different
from the HPV types associated with anogenital warts, clinicians should probably
not use the term condyloma acuminata to describe oral HPV lesions.
Clinical Features
HPV lesions in the oral cavity may appear as solitary or multiple nodules. They
may be sessile or pedunculated and appear as multiple, smooth-surfaced raised masses
resembling focal epithelial hyperplasia or as multiple, small papilliferous or cauliflower-like
projections.
Differential Diagnosis
A biopsy is necessary for histologic diagnosis.
Prognosis
There is no known association between oral HPV lesions and more rapid progression
of HIV disease, but oral warts are seen more commonly in HIV- infected persons than
in the general population.
Treatment
Oral HPV lesions can be removed surgically using local anesthetic. Carbon dioxide
laser surgery can remove multiple flat warts, but relapses occur and several repeat
procedures may be necessary.
Cytomegalovirus
Oral ulcers caused by cytomegalovirus (CMV) have been reported. These ulcers can
appear on any mucosal surface and may be confused with aphthous ulcers, necrotizing
ulcerative periodontitis (NUP) and lymphoma. Unlike aphthous ulcers, however, which
usually have an erythematous margin, CMV ulcers appear necrotic with a white halo.
Diagnosis of CMV ulcers is made from a biopsy. Immunohistochemistry may be helpful.
CMV ulcers in the oral cavity usually occur in individuals with disseminated CMV
disease. Therefore, diagnosis of CMV-infected oral ulcers should be followed by
examination for the systemic disease. CMV ulcers resolve when ganciclovir is used
to treat CMV disease.
Hairy Leukoplakia and Epstein-Barr Virus
Oral hairy leukoplakia (HL), which presents as a nonmovable, corrugated or "hairy"
white lesion on the lateral margins of the tongue, occurs in all risk groups for
HIV infections, although less commonly in children than in adults. HL occurs in
about 20% of persons with asymptomatic HIV infection and becomes more common as
the CD4 + T-cell count falls. HL is in group 4, category C2 of the original Centers
for Disease Control (CDC) definition of AIDS and in B3 of the 1993 criteria. No
report describes HL in mucosal sites other than the mouth.HL has occurred in non-HIV-infected
people including recipients of bone marrow, cardiac and renal transplants.
Hairy Leukoplakia and Progression of HIV Disease
Diagnosis of HL is an indication of both HIV infection and immunodeficiency; it
is an indication for a work-up to evaluate and treat HIV disease. HL correlates
with a statistical risk for more rapid progression of HIV disease. In an early study,
30% of persons with HL progressed to late-stage HIV disease characterized by CDC-defined
AIDS within 36 months. In a later study, 47% of a group developed CDC-defined AIDS
within 2 years and 67% within four years.Those persons with HL who progressed to
CDC-defined AIDS most rapidly, however, were more often anergic to Candida antigen
at diagnosis of HL, indicating significant immunosuppression at that time. Progression
to CDC- defined AIDS was more rapid in those HIV-infected persons with HL than in
those without HL, even after adjustment for CD4 + T-cell count.
Pathogenesis
The Epstein-Barr virus (EBV) in HL is both unusual in that deletions in the EBNA
2 gene have been described and till date no viral DNA is found in the basal layers
of HIV. Intraepithelial Langerhans' cells (LCs) are reduced or absent in the HL
lesion, which correlates with the presence of viral antigens. It is not known whether
the lack of LCs is a cause of HL or a consequence of EBV infection.
Clinical Appearance and Manifestations
HL lesions vary in size and appearance and may be unilateral or bilateral. The surface
is irregular and may have prominent folds or projections, sometimes markedly resembling
hairs. Occasionally, however, some areas may be smooth and flat. Lesions occur most
commonly on the lateral margins of the tongue and may spread to cover the entire
dorsal surface . They may also spread downward onto the ventral surface of the tongue,
where they usually appear flat. HL lesions can also occur on the buccal mucosa,
generally as flat lesions. Rarely, lesions occur on the soft palate. HL usually
does not cause symptoms.
Differential Diagnosis
Candida albicans may be found in association with many HL lesions and hyphae can
be seen in specimens taken from lesions and examined using potassium hydroxide.
Hyphae can be seen in sections stained with periodic acid- Schiff. Administration
of antifungal drugs may change the appearance of the lesions but does not cause
them to disappear. Clinicians must distinguish them from other white lesions, such
as lichen planus, idiopathic leukoplakia, white sponge nevus, dysplasia and squamous
cell carcinoma.
Diagnosis
HL should be diagnosed by biopsy for definitive diagnosis. Experienced clinicians
can make a presumptive diagnosis of HL in association with HIV disease from the
clinical appearance, although HL can be confused with oral candidiasis. The typical
microscopic appearance of HL includes acanthosis, marked parakeratosis with the
formation of ridges and keratin projections, areas of ballooning cells and little
or no inflammation in the connective tissue. The ballooning changes resemble koilocytosis.
Cells are enlarged; some contain enlarged ballooning cells with pyknotic nuclei.
Some contain perinuclear haloes. Definitive diagnosis of HL requires demonstration
of EBV. EBV may be readily demonstrated in biopsy specimens by a variety of techniques.
Cells taken from the HL lesion by scraping can be used for a noninvasive diagnosis
using in situ hybridization.
Treatment
Hairy leukoplakia usually is asymptomatic and does not require treatment. HL is
almost always a manifestation of HIV infection and clinicians should arrange evaluation
of HIV disease and appropriate treatment for patients with HL. HL has disappeared
in patients receiving high-dose acyclovir for herpes zoster, presumably because
of the anti- EBV activity of acyclovir. Doses of acyclovir (2.5 to 3 mg per day
for 2 to 3 weeks) usually eliminate HL, but the lesion usually recurs with cessation
of treatment. Elimination or almost complete clinical resolution of the lesion has
occurred in patients treated with agents such as desciclovir, an analog of acyclovir,(55)
phosphonoformate, Retin A and podophyllin resin, although lesions tend to recur
within a few months. Occasionally, Candida albicans may be found in HL lesions.
Treatment consists of antifungal medications.
Bacterial Lesions
Periodontal Disease
Periodontal disease is a fairly common problem in both asymptomatic and symptomatic
HIV-infected patients. It can take two forms: The rapid and severe condition called
necrotizing ulcerative periodontitis (NUP) and its associated and possibly precursor
condition called linear gingival erythema (LGE). The presenting clinical features
of these diseases often differ from those in non-HIV-infected persons.
Clinical Features
LGE and NUP often occur in clean mouths where there is very little plaque or calculus
to account for the gingivitis. The onset is often sudden, with rapid loss of bone
and soft tissue. In LGE, the gingiva may be reddened and edematous. Patients sometimes
complain of spontaneous bleeding. In acute-onset ulcerative gingivitis, ulcers occur
at the tips of the interdental papilla and along the gingival margins and often
elicit complaints of severe pain. The ulcers heal, leaving the gingival papillae
with a characteristic cratered appearance. NUP may present as rapid loss of supporting
bone and soft tissue. Typically, these losses occur simultaneously with no formation
of gingival pockets, sometimes involving only isolated areas of the mouth. Teeth
may loosen and eventually fall out, but uninvolved sites can appear healthy. Necrotizing
stomatitis may develop and areas of necrotic bone may appear along the gingival
margin. The bone may eventually sequestrate. Patients with NUP and necrotizing stomatitis
frequently complain of extreme pain and spontaneous bleeding.
Differential Diagnosis
The patient's history and clinical appearance help in making the diagnosis. It is
sometimes difficult to distinguish this type of periodontal disease from non-HIV-related
periodontal disease. However, the complaints of severe pain, rapid onset, and rapid
destruction in an often extremely clean mouth are unusual for non- HIV-related periodontal
disease.
Treatment
The following protocol has achieved reasonable success: Plaque removal, local debridement,
irrigation with povidone-iodine, scaling and root planing, and maintenance with
a chlorhexidine mouth rinse (Peridex-R) once or twice daily. Studies show that the
addition of chlorhexidine to this regimen produces significant improvement in periodontal
condition. In cases of NUP, metronidazole (one 250-mg tablet four times daily),
amoxicillin/clavulanate (Augmentin)(one 250-mg tablet three times daily) or clindamycin
(one 300-mg tablet three times daily) should be added to the treatment regimen
Different Course in HIV Infection
The microbiology of periodontal disease in HIV-infected patients has not been fully
described. Oral flora associated with LGE and NUP appear to be similar to those
associated with periodontal disease seen in non- HIV-infected persons. Recurrences
of acute episodes are common and response to conventional treatment may be poor.
However, therapeutic strategies and frequent recall appointments can produce effective
local treatment of LGE and NUP. There is as yet no known relationship between these
conditions and the progression of HIV disease.
Mycobacterium Avium Intracellulare
Mycobacterium avium-intracellulare has been reported to have presented as palatal
and gingival granulomatous masses in the oral cavity. A diagnosis requires biopsy
specimen of acid fast bacilli cultured from blood and sputum and a special stain.
Neoplastic Lesions
Kaposi's Sarcoma
Kaposi's sarcoma (KS) may occur intraorally, either alone or in association with
skin and disseminated lesions. Intraoral lesions have been reported at other sites
and may be the first manifestation of late-stage HIV disease (AIDS). KS occurs most
commonly in men but also has been observed in women.
Clinical Features
KS can appear as a red, blue or purplish lesion. It may be flat or raised, solitary
or multiple. The most common oral site is the hard palate, but lesions may occur
on any part of the oral mucosa, including the gingiva, soft palate and buccal mucosa,
and in the oropharynx. Occasionally, yellowish mucosa surrounds the KS lesion. Oral
KS lesions may enlarge, ulcerate and become infected. Good oral hygiene is essential
to minimize these complications.
Differential Diagnosis
KS must be distinguished from vascular lesions such as hematomas, hemangiomas, other
vascular tumours, pyogenic granulomas, bacillary angiomatosis,(69) and pigmented
lesions such as oral melanotic macules. Diagnosis is made from histologic examination.(70,71)
There are usually no bleeding problems associated with a biopsy of oral KS. However,
aspiration of a lesion prior to biopsy may be useful to rule out a hemangioma. Small,
flat lesions are probably in early stages and the histologic appearance is different
from the larger, nodular lesions that are probably more advanced. Early lesions
may be difficult to diagnose histologically because they resemble endothelial proliferation.
KS may appear suddenly, within days of a normal oral examination, in previously
uninvolved areas of the mouth. Providers should ensure that a patient with KS receives
evaluation and follow-up care for the underlying HIV disease.
Treatment
Treatment is determined on the basis of the number, size and location of the oral
KS lesions. The choice of therapy depends on the effect of treatment on the adjacent
mucosa, pain associated with treatment, interference with eating and speaking and
the patient's preference. It is important to perform thorough dental prophylaxis
before initiating therapy for KS lesions involving the gingiva. Response to therapy
is improved if all local plaque and calculus are removed. Local application of sclerosing
agents may reduce the size of oral lesions.
Local treatment is appropriate for large oral KS lesions that interfere with eating
and talking. Oral KS can be treated surgically or with localized intralesional chemotherapy.
Surgical removal is suitable for small, well- circumscribed lesions such as gingival
or tongue lesions. Surgical removal can be performed under local anesthesia with
a blade or with the carbon dioxide laser. Intralesional vinblastine is useful for
treating small lesions, particularly on the palate or gingiva. Several studies have
documented the effectiveness of one or two injections of 0.1 to 0.2 mg per ml solution
of vinblastine. Post treatment pain is fairly common, but systemic effects are rare.
The pain usually disappears several days after therapy.
Radiation therapy may be indicated for large, multiple lesions. A single dose of
800 cGy or an equivalent fractionated dose is frequently used and produces a good
response. Side effects include xerostomia and mucositis, although both conditions
usually improve with cessation of radiation therapy.
Lymphoma
Clinical Features
Diffuse, undifferentiated non-Hodgkin's lymphoma (NHL) is a frequent HIV-associated
malignancy. Most are of B cell origin, and Epstein-Barr virus occurs in cells from
several cases. Lymphoma can occur anywhere in the oral cavity and there may be soft
tissue involvement with or without involvement of underlying bone. The lesion may
present as firm, painless swelling that may be ulcerated. Some oral lesions may
appear as shallow ulcerations. Oral NHL may appear as solitary lesions with no evidence
of disseminated disease.
Differential Diagnosis
Oral NHL may be confused with major aphthous ulcers and rarely as a pericoronitis
associated with an erupting third molar. Diagnosis of NHL must be made by histologic
examination of biopsy specimens.
Treatment
After diagnosis of the oral lesions, the patient must be referred for further evaluation
for disseminated disease and its subsequent treatment.
Other Lesions Associated with HIV
Oral Ulcerations
Other Oral Lesions Associayed With HIV Disease
Oral ulcers resembling recurrent aphthous ulcers (RAUs) in HIV-infected persons are reported with increasing frequency. The cause of these ulcers is unknown. Proposed causes include stress and unidentified infectious agents. In HIV-infected patients, the ulcers are well circumscribed with erythematous margins.
The ulcers can be classified as:
- The minor RAU type may appear as solitary lesions of about 0.5 to 1.0 cm.
- The herpetiform type appear as clusters of small ulcers (1 to 2 mm), usually on the soft palate and oropharynx.
- The major RAU type appears as extremely large (2 to 4 cm) necrotic ulcers. The major RAUs are very painful and may persist for several weeks.
Diagnosis
The ulcers may present a diagnostic problem. Herpetiform RAUs may resemble the lesions of coxsackievirus infection and major RAUs may require biopsy to exclude malignancy, such as lymphoma or opportunistic infection, such as histoplasmosis. The ulcers usually occur on nonkeratinized mucosa; this characteristic differentiates them from those caused by herpes simplex.
Treatment
The RAU type ulcers usually respond well to topical steroids such as fluocinonide (0.05%) ointment mixed with equal parts Orabase applied six times daily or clobetasol (0.05%) ointment mixed with equal parts Orabase applied three times per day. Dexamethasone elixir (0.5 mg/5 ml) used as a mouth rinse and then expectorated two to three times daily is helpful for multiple ulcers and for those where topical ointments are hard to apply. For HIV- infected persons with oral and gastrointestinal aphthous-like ulcers, systemic steroid therapy (prednisone 40 to 60 mg/day for 7 to 10 days) has been reported as helpful. The risks of steroid therapy, however, must be considered before administration to individuals in this population.
Top
Thrombocytopenic Purpura
Reports have described idiopathic thrombocytopenic purpura (ITP) in HIV-infected patients. Oral lesions may be the first manifestation of this condition.
Clinical Features
Petechiae, ecchymoses and hematoma can occur anywhere on the oral mucosa. Spontaneous bleeding from the gingiva can occur and patients may report finding blood in their mouth on waking.
Differential Diagnosis
The clinician must distinguish ITP from other vascular lesions and KS. Because of potential bleeding risk, the clinician should obtain blood and platelet counts before performing other diagnostic procedures.
Top
Salivary Gland Diseases and Xerostomia
Salivary gland disease associated with HIV infection (HIV-SGD) can present as xerostomia with or without salivary gland enlargement. Reports describe salivary gland enlargement in children and adults with HIV infection usually involving the parotid gland. The enlarged salivary glands are soft but not fluctuant. In some cases, enlarged salivary glands may be due to lymphoepithelial cysts. Schiodt et al. found that 9 of 12 patients (11 adults and 1 child) with HIV-SGD had salivary gland enlargement. Three had xerostomia. Labial salivary gland biopsy revealed histologic features similar to those in Sjogren's syndrome. In HIV-SGD, however, the lymphocytic infiltrate is predominantly CD8 cells, unlike that in Sjogren's syndrome, which is predominantly CD4 cells.
No evidence of Epstein-Barr virus or cytomegalovirus has been found in biopsies of salivary glands. One report describes an association between HIV-SGD and HLA-DR5 and HLA-B35 cell-surface antigen.
The etiology of HIV-SGD is as yet unknown but the enlarged parotid glands can be a source of annoyance and discomfort.
Xerostomia is sometimes seen in individuals with HIV-SGD. HIV-infected patients may also experience dry mouth in association with taking certain medications that can hinder salivary secretion, such as antidepressants, antihistamines and anti anxiety drugs.
Management
Removal of the enlarged parotid glands is rarely recommended. For individuals with xerostomia, the use of salivary stimulants such as sugarless gum or sugarless candies may provide relief. Candies that are acidic should be avoided as frequent use may lead to loss of tooth enamel. The use of salivary substitutes may also be helpful. An increase in caries can occur, so fluoride rinses (that can be bought over the counter) should be used daily, and visits to the dentist should be recommended two to three times per year.